Dunn, Kelly E.

A Double-Blind, Placebo-Controlled Trial Assessing the Efficacy of Varenicline Tartrate for Alcohol Dependence

Litten, R. Z., Ryan, M. L., Fertig, J. B., Falk, D. E., Johnson, B., Dunn, K. E., Green, A. I., Pettinati, H. M., Ciraulo, D. A., Sarid-Segal, O., et al. (2013) · Journal of Addiction Medicine

Substance Abuse Treatment and OutcomesAlcohol Consumption and Health Effects

Cited by 287

Gabapentin enacarbil extended-release for alcohol use disorder: a randomized, double-blind, placebo-controlled, multisite trial assessing efficacy and safety

Falk, D. E., Ryan, M. L., Fertig, J. B., Devine, E. G., Cruz, R., Brown, E. S., Burns, H., Salloum, I. M., Newport, D. J., Mendelson, J., et al. (2019) · Alcoholism: Clinical and Experimental Research

Substance Abuse Treatment and OutcomesAlcohol Consumption and Health Effects

Cited by 89

Suvorexant ameliorated sleep disturbance, opioid withdrawal, and craving during a buprenorphine taper

Huhn, A. S., Finan, P. H., Gamaldo, C. E., Hammond, A. S., Umbricht, A., Bergeria, C. L., Strain, E. C., & Dunn, K. E. (2022) · Science Translational Medicine

Opioid Use Disorder TreatmentSubstance Abuse Treatment and Outcomes

Cited by 79

A Phase 2, Double-Blind, Placebo-Controlled Randomized Trial Assessing the Efficacy of ABT-436, a Novel V1b Receptor Antagonist, for Alcohol Dependence

for the National Institute on Alcohol Abuse and Alcoholism Clinical Investigations Group (NCIG) Study Group, Ryan, M. L., Falk, D. E., Fertig, J. B., Rendenbach-Mueller, B., Katz, D. A., Tracy, K. A., Strain, E. C., Dunn, K. E., Kampman, K., et al. (2017) · Neuropsychopharmacology

Substance Abuse Treatment and OutcomesAlcohol Consumption and Health Effects

Cited by 72

The association between outpatient buprenorphine detoxification duration and clinical treatment outcomes: A review

Dunn, K. E., Sigmon, S. C., Strain, E. C., Heil, S. H., & Higgins, S. T. (2011) · Drug and Alcohol Dependence

Opioid Use Disorder TreatmentSubstance Abuse Treatment and Outcomes

Cited by 65

Characterizing pain and associated coping strategies in methadone and buprenorphine-maintained patients

Dunn, K. E., Finan, P. H., Tompkins, D. A., Fingerhood, M., & Strain, E. C. (2015) · Drug and Alcohol Dependence

Opioid Use Disorder TreatmentPain Management and Opioid Use

Cited by 50

The relationship between treatment accessibility and preference amongst out-of-treatment individuals who engage in non-medical prescription opioid use

Huhn, A. S., Tompkins, D. A., & Dunn, K. E. (2017) · Drug and Alcohol Dependence

Opioid Use Disorder TreatmentSubstance Abuse Treatment and Outcomes

Cited by 45

Dopamine Supersensitivity: A Novel Hypothesis of Opioid-Induced Neurobiological Mechanisms Underlying Opioid-Stimulant Co-use and Opioid Relapse

Strickland, J. C., Gipson, C. D., & Dunn, K. E. (2022) · Frontiers in Psychiatry

Opioid Use Disorder TreatmentNeurotransmitter Receptor Influence on Behavior

Cited by 31